Studies on copper(II) complexes with β-alanine: Synthesis, X-ray crystal structure, cytotoxic activity, and DFT calculations
Исследование комплексов меди(II) с β-аланином: синтез, рентгеноструктура, цитотоксическая активность и расчёты DFT
2025-07-19
SCID: 54.1/szsamuw9
Discuss with AI
DFT calculationsX-ray crystal structurecopper(II) complexescytotoxic activity (MTT assay)β-alanine (β-Ala)
Figures from the paper
Abstract (AI)
The present work is devoted to studies on the interaction of copper(II)- chloride, bromide, and nitrate with β-alanine (β-Ala, 3-aminopropanoic acid, NH 2 (CH 2 ) 2 COOH). The complex compounds [Cu 2 (μ 2 -β-Ala) 4 × 2 ]X 2 ∙nH 2 O X = Cl ( n = 1) (1) , Br ( n = 2) (2) , [Cu 2 (μ 2 -β-Ala) 4 (H 2 O) 2 ](NO 3 ) 4 ∙4H 2 O (3) have been prepared in aqueous solutions from the initial copper salts and β-Ala taken in the molar ratio of CuX 2 :β-Ala = 1:2. All the complexes have been characterized by the powder-, single crystal X-ray diffraction analysis, IR-, ESI-MS-spectroscopy, elemental analysis. The cytotoxic activity (MTT assay) on the postnatal human dental pulp stem cells (DPSC) and the MCF-7 breast cancer cell line was found to be the dose-dependent one for both types of cells, [Cu 2 (μ 2 -β-Ala) 4 Br 2 ]Br 2 ∙2H 2 O ( 2 ) demonstrating the highest difference in cytotoxicity for DPSC and MCF-7 at a concentration of 1∙10 −4 and 5∙10 −4 mol/L (survivability: 28.64 ± 2.08 and 5.44 ± 0.68 (MCF-7) and (61.57 ± 4.49 and 22.01 ± 1.74 % (DPSC)), in comparison with doxorubicin (Dox): 64.87 ± 12.68 % (DPSC); 68.97 ± 7.55 % (MCF-7)) at c = 1∙10 −4 mol/L. Quantum-chemical calculations (DFT method) allowed to predict the direction of complex formation and thermodynamic stability of the complexes obtained.
Key Findings
1
All complexes were characterized by single-crystal and powder X-ray diffraction, IR, ESI-MS spectroscopy, and elemental analysis confirming their binuclear structures.
2
At 1·10−4 mol/L, complex (2) reduced MCF-7 survivability to 5.44 ± 0.68% and DPSC survivability to 61.57 ± 4.49%, compared to doxorubicin survivabilities of 68.97 ± 7.55% (MCF-7) and 64.87 ± 12.68% (DPSC).
3
Cytotoxicity (MTT assay) against MCF-7 breast cancer and human dental pulp stem cells (DPSC) was dose-dependent, with complex (2) showing the largest differential toxicity between cancer and healthy cells at 1·10−4 and 5·10−4 mol/L.
4
DFT quantum-chemical calculations predicted the direction of complex formation and supported the thermodynamic stability of the synthesized copper(II)-β-alanine complexes.
5
Three binuclear copper(II)-β-alanine complexes were synthesized: [Cu2(μ2-β-Ala)4×2]Cl2·H2O (1), [Cu2(μ2-β-Ala)4×2]Br2·2H2O (2), and [Cu2(μ2-β-Ala)4(H2O)2](NO3)4·4H2O (3).
Research Object
Binuclear copper(II) complexes with β-alanine (specifically [Cu2(μ2-β-Ala)4·2]X2·nH2O and [Cu2(μ2-β-Ala)4(H2O)2](NO3)4·4H2O prepared from CuCl2, CuBr2, Cu(NO3)2)
Research Subject
Their synthesis, crystal structures (single-crystal and powder X-ray diffraction), cytotoxic activity against DPSC and MCF-7 cells (dose-dependent MTT assay), and thermodynamic stability/predicted formation direction from DFT calculations
Publication Details
Publication Date
2025-07-19
Journal
Publisher
ISSN
Cited by
0
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest